NEVVI Medicare utilization intelligence
or

← back

Provider profile

JENKINS, ALFRED MD

Gynecological Oncology · NPI 1487686200 · TULSA, OK

1
Groups
31
Codes · 2024
11,250
Disclosed services

JENKINS, ALFRED is a Gynecological Oncology in TULSA, OK, a member of 1 medical group, who billed 31 distinct codes to Medicare Part B in 2024.

Groups: OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC (TULSA, OK)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

11,250
disclosed services
31
codes billed to Medicare Part B
Prior year · CY2023 27,096 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
83615 Lactate dehydrogenase (enzyme) level
83735 Magnesium level
84100 Phosphate level
84550 Uric acid level, blood
80053 Blood test, comprehensive group of blood chemicals
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
36415 Insertion of needle into vein for collection of blood sample
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
99459 Pelvic exam
96372 Injection of drug or substance under skin or into muscle
36591 Collection of blood sample from implanted device
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
71260 Ct scan of chest with contrast
74177 Ct scan of abdomen and pelvis with contrast
96417 Administration of additional new drug or substance into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
58571 Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less
82565 Blood creatinine level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J3490 Unclassified drugs
96523 Irrigation of implanted venous access drug delivery device
38900 Imaging of lymph nodes during surgery

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.